PT87542A - Process for the preparation of a medicament based on indolone derivatives for the treatment of the parkinson disease - Google Patents

Process for the preparation of a medicament based on indolone derivatives for the treatment of the parkinson disease

Info

Publication number: PT87542A
Authority: PT; Portugal
Prior art keywords: preparation; treatment; parkinson disease; indolone derivatives; medicinal
Prior art date: 1987-05-21

Application number

PT87542A

Other languages

English (en)

Other versions

PT87542B (pt

Inventor

David Andrew Arwydd Owen

Original Assignee

Smith Kline French Lab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1987-05-21

Filing date

1988-05-20

Publication date

1989-05-31

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10617727&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT87542(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1988-05-20 Application filed by Smith Kline French Lab filed Critical Smith Kline French Lab

1989-05-31 Publication of PT87542A publication Critical patent/PT87542A/pt

1992-09-30 Publication of PT87542B publication Critical patent/PT87542B/pt

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Indole Compounds (AREA)
Medicinal Preparation (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

PT87542A 1987-05-21 1988-05-20 Processo de preparacao de um medicamento a base de derivados da indolona para o tratamento da doenca de parkinson PT87542B (pt)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GB878712073A GB8712073D0 (en)	1987-05-21	1987-05-21	Medicament

Publications (2)

Publication Number	Publication Date
PT87542A true PT87542A (pt)	1989-05-31
PT87542B PT87542B (pt)	1992-09-30

Family

ID=10617727

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PT87542A PT87542B (pt)	1987-05-21	1988-05-20	Processo de preparacao de um medicamento a base de derivados da indolona para o tratamento da doenca de parkinson

Country Status (21)

Country	Link
US (2)	US4824860A (pt)
EP (1)	EP0299602B1 (pt)
JP (1)	JPH062672B2 (pt)
AT (1)	ATE83659T1 (pt)
AU (1)	AU599792B2 (pt)
CA (1)	CA1305421C (pt)
DE (1)	DE3876877T2 (pt)
DK (1)	DK169609B1 (pt)
ES (1)	ES2052717T3 (pt)
GB (1)	GB8712073D0 (pt)
GR (1)	GR3007251T3 (pt)
HK (1)	HK1000913A1 (pt)
HU (1)	HU201871B (pt)
IE (1)	IE63511B1 (pt)
LU (1)	LU90098I2 (pt)
MX (1)	MX9203543A (pt)
NL (1)	NL970006I2 (pt)
NZ (1)	NZ224709A (pt)
PH (1)	PH23867A (pt)
PT (1)	PT87542B (pt)
ZA (1)	ZA883602B (pt)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9008605D0 (en) *	1990-04-17	1990-06-13	Smith Kline French Lab	Process
GB9015095D0 (en) *	1990-07-09	1990-08-29	Smith Kline French Lab	Therapeutic method
WO1993023035A2 (en) *	1992-05-18	1993-11-25	Smithkline Beecham Plc	Use of indolone derivatives for the treatment of memory disorders, sexual dysfunction and parkinson's disease
GB9300309D0 (en) *	1993-01-08	1993-03-03	Smithkline Beecham Plc	Process
GB9511366D0 (en) *	1995-06-06	1995-08-02	Smithkline Beecham Plc	Novel formulations
GB9517062D0 (en) *	1995-08-18	1995-10-25	Scherer Ltd R P	Pharmaceutical compositions
US5807570A (en) *	1995-09-29	1998-09-15	Cygnus, Inc.	Transdermal administration of ropinirole and analogs thereof
GB9612752D0 (en) *	1996-06-19	1996-08-21	Smithkline Beecham Plc	Novel treatment
KR20000035818A (ko) *	1996-08-27	2000-06-26	이곤 이 버그	4-아미노에톡시 인돌론 유도체
AR014847A1 (es) *	1998-04-13	2001-03-28	American Home Prod	4-amino-(etilamino)-oxindoles agonistas del autoreceptor de dopamina y una composicion farmaceutica que los comprende
US6176242B1 (en)	1999-04-30	2001-01-23	Medtronic Inc	Method of treating manic depression by brain infusion
US6218421B1 (en) *	1999-07-01	2001-04-17	Smithkline Beecham P.L.C.	Method of promoting smoking cessation
AR030557A1 (es)	2000-04-14	2003-08-27	Jagotec Ag	Una tableta en multicapa de liberacion controlada y metodo de tratamiento
US6277875B1 (en) *	2000-07-17	2001-08-21	Andrew J. Holman	Use of dopamine D2/D3 receptor agonists to treat fibromyalgia
DE10041478A1 (de) *	2000-08-24	2002-03-14	Sanol Arznei Schwarz Gmbh	Neue pharmazeutische Zusammensetzung
US7858602B2 (en) *	2000-10-16	2010-12-28	Rodriguez Victorio C	Therapeutic and prophylactic uses of cell specific carbonic anhydrase enzymes in treating aging disorders due to oxidative stress and as growth factors of stem cells
US6871098B2 (en) *	2000-10-30	2005-03-22	Medtronic, Inc.	Method for treating obsessive-compulsive disorder with electrical stimulation of the brain internal capsule
CA2498735C (en) *	2002-09-13	2011-08-02	Motac Neuroscience Limited	Treatment of basal ganglia-related movement disorders with 2,3-benzodiazepines
DK1539135T3 (da) *	2002-09-17	2007-09-17	Motac Neuroscience Ltd	Behandling af dyskinesi
DE10334188B4 (de) *	2003-07-26	2007-07-05	Schwarz Pharma Ag	Verwendung von Rotigotin zur Behandlung von Depressionen
DE10334187A1 (de) *	2003-07-26	2005-03-03	Schwarz Pharma Ag	Substituierte 2-Aminotetraline zur Behandlung von Depressionen
WO2005051488A1 (en) *	2003-11-26	2005-06-09	Pfizer Products Inc.	Combination of dopamine agonists and monoamine reuptake inhibitors
DE10361258A1 (de) *	2003-12-24	2005-07-28	Schwarz Pharma Ag	Verwendung von substituierten 2-Aminotetralinen zur vorbeugenden Behandlung von Morbus Parkinson
US7378439B2 (en) *	2004-01-20	2008-05-27	Usv, Ltd.	Process for the preparation of 4-(2-dipropylaminoethyl)-1,3-dihydro-2H-indol-2-one hydrochloride
US20050197385A1 (en) *	2004-02-20	2005-09-08	Schwarz Pharma Ag	Use of rotigotine for treatment or prevention of dopaminergic neuron loss
DE102004014841B4 (de) *	2004-03-24	2006-07-06	Schwarz Pharma Ag	Verwendung von Rotigotin zur Behandlung und Prävention des Parkinson-Plus-Syndroms
WO2007048034A2 (en) *	2005-10-21	2007-04-26	Caritas St. Elizabeth Medical Center Of Boston, Inc.	Use of androgens for the treatment of parkinson' s disease
SI2010184T1 (sl)	2006-04-06	2013-05-31	Nupathe Inc.	Implantati za zdravljenje stanj, povezanih z dopaminom
TW200815045A (en) *	2006-06-29	2008-04-01	Jazz Pharmaceuticals Inc	Pharmaceutical compositions of ropinirole and methods of use thereof
WO2008001204A2 (en) *	2006-06-29	2008-01-03	Antares Pharma Ipl Ag	Transdermal compositions of pramipexole having enhanced permeation properties
US20090247537A1 (en) *	2008-03-25	2009-10-01	William Dale Overfield	Methods for preventing or treating bruxism using dopaminergic agents
CN101574341B (zh) *	2008-05-05	2012-12-19	北京德众万全医药科技有限公司	一种罗匹尼罗的口服固体药物组合物
US20110195117A1 (en) *	2008-09-01	2011-08-11	Lupin Limited	Controlled release compositions of ropinirole
WO2010035245A2 (en)	2008-09-29	2010-04-01	Wockhardt Research Centre	Extended release dosage form of ropinirole
WO2010044108A2 (en)	2008-10-17	2010-04-22	Rubicon Research Private Limited	Controlled release formulations of ropinirole
US20100233259A1 (en) *	2008-12-12	2010-09-16	Pascal Grenier	Dosage form of ropinirole
PH12012501777A1 (en)	2010-04-30	2012-11-12	Teikoku Pharma Usa Inc	Propynylaminoindan transdermal compositions
KR101853082B1 (ko)	2011-03-24	2018-04-27	테이코쿠 팔마 유에스에이, 인코포레이티드	활성제층 및 활성제 변환층을 포함하는 경피 조성물
WO2013070526A1 (en)	2011-11-09	2013-05-16	Teikoku Pharma Usa, Inc.	Methods for the treatment of skin neoplasms
NZ706590A (en)	2012-11-02	2016-02-26	Teikoku Pharma Usa Inc	Propynylaminoindan transdermal compositions
WO2015168616A1 (en) *	2014-05-02	2015-11-05	Abbvie Inc.	Neuronal nicotinic agonists and methods of use

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4588740A (en) *	1982-12-07	1986-05-13	Smithkline Beckman Corporation	Pharmaceutical methods using 4-aminoalkyl-2(3H)-indolones
US4452808A (en) *	1982-12-07	1984-06-05	Smithkline Beckman Corporation	4-Aminoalkyl-2(3H)-indolones

1987
- 1987-05-21 GB GB878712073A patent/GB8712073D0/en active Pending
1988
- 1988-05-16 IE IE146988A patent/IE63511B1/en not_active IP Right Cessation
- 1988-05-16 PH PH36934A patent/PH23867A/en unknown
- 1988-05-17 CA CA000566974A patent/CA1305421C/en not_active Expired - Lifetime
- 1988-05-19 DE DE8888304555T patent/DE3876877T2/de not_active Expired - Lifetime
- 1988-05-19 DK DK275488A patent/DK169609B1/da not_active IP Right Cessation
- 1988-05-19 AT AT88304555T patent/ATE83659T1/de active
- 1988-05-19 AU AU16445/88A patent/AU599792B2/en not_active Expired
- 1988-05-19 ES ES88304555T patent/ES2052717T3/es not_active Expired - Lifetime
- 1988-05-19 EP EP88304555A patent/EP0299602B1/en not_active Expired - Lifetime
- 1988-05-19 US US07/196,653 patent/US4824860A/en not_active Expired - Lifetime
- 1988-05-19 NZ NZ224709A patent/NZ224709A/en unknown
- 1988-05-20 JP JP63124816A patent/JPH062672B2/ja not_active Expired - Lifetime
- 1988-05-20 HU HU882611A patent/HU201871B/hu unknown
- 1988-05-20 PT PT87542A patent/PT87542B/pt not_active IP Right Cessation
- 1988-05-20 ZA ZA883602A patent/ZA883602B/xx unknown
1989
- 1989-03-13 US US07/322,386 patent/US4912126A/en not_active Expired - Lifetime
1992
- 1992-06-26 MX MX9203543A patent/MX9203543A/es unknown
1993
- 1993-03-05 GR GR930400472T patent/GR3007251T3/el unknown
1997
- 1997-02-05 NL NL970006C patent/NL970006I2/xx unknown
- 1997-07-16 LU LU90098C patent/LU90098I2/fr unknown
- 1997-12-19 HK HK97102520A patent/HK1000913A1/xx not_active IP Right Cessation

Also Published As

Publication number	Publication date
IE881469L (en)	1988-11-21
HU201871B (en)	1991-01-28
NZ224709A (en)	1997-02-24
MX9203543A (es)	1992-07-01
NL970006I2 (nl)	1997-10-01
EP0299602A2 (en)	1989-01-18
DE3876877D1 (de)	1993-02-04
PH23867A (en)	1989-11-23
EP0299602A3 (en)	1990-06-06
HK1000913A1 (en)	1998-05-08
ATE83659T1 (de)	1993-01-15
US4912126A (en)	1990-03-27
GR3007251T3 (pt)	1993-07-30
NL970006I1 (nl)	1997-04-01
IE63511B1 (en)	1995-05-03
CA1305421C (en)	1992-07-21
PT87542B (pt)	1992-09-30
GB8712073D0 (en)	1987-06-24
DK275488D0 (da)	1988-05-19
LU90098I2 (fr)	1997-09-25
DK275488A (da)	1988-11-22
EP0299602B1 (en)	1992-12-23
DK169609B1 (da)	1994-12-27
JPH062672B2 (ja)	1994-01-12
AU599792B2 (en)	1990-07-26
ZA883602B (en)	1989-04-26
JPS63303966A (ja)	1988-12-12
US4824860A (en)	1989-04-25
AU1644588A (en)	1988-11-24
DE3876877T2 (de)	1993-04-29
ES2052717T3 (es)	1994-07-16
HUT47217A (en)	1989-02-28

Publication	Publication Date	Title
PT87542A (pt)	1989-05-31	Process for the preparation of a medicament based on indolone derivatives for the treatment of the parkinson disease
NO166448C (no)	1991-07-24	Analogifremgangsmaate for fremstilling av terapeutisk aktive tiazolidindioner.
EE02995B1 (et)	1997-06-16	1,3-oksatiolaannukleosiidi analoogide kasutamine hepatiit B ravimpreparaatide valmistamiseks
FI862011A (fi)	1986-11-16	Terapeutiska nukleosider.
HU913283D0 (en)	1992-01-28	Process for the production of hydroximethyl-(methylene-cyclopentyl)-purines and pirimidines, their medically usable salts, and of medical preparations containing them
DE3875769D1 (de)	1992-12-17	Therapeutische nukleoside.
UA19756A1 (uk)	1997-12-25	Спосіб одержаhhя піперазиhілалкіл-3(2h)піридазиhоhів або їх фармацевтичhо прийhятих солей
ES2108680T3 (es)	1998-01-01	Uso del derivado n-n-butilo de desoxinojirimicina en la fabricacion de un medicamento.
DE68927055D1 (de)	1996-10-02	2',5'-oligoadenylat-derivate zur verwendung als heilmittel
DK557189A (da)	1990-05-30	1,2,3,4-tetrahydro-1,9-acridindiaminer, deres fremstilling og anvendelse som laegemidler
GB8608893D0 (en)	1986-05-14	D-nor-7-ergoline derivatives
FI894813A0 (fi)	1989-10-11	Menetelmä terapeuttisesti aktiivisten 2-metoksikarbonyylisubstituoitujen N,N'-di(trimetoksibentsoyyli)piperatsiinijohdannaisten valmistamiseksi
EP0202986A3 (en)	1990-05-16	Use of "naftidrofuryl" in the treatment of neuropathies
EP0207514A3 (en)	1987-06-16	1,4-dihydropyridine derivatives, process for preparing them, pharmaceutical composition and use

Legal Events

Date	Code	Title	Description
1992-09-30	FG3A	Patent granted, date of granting	Effective date: 19920311
2008-06-03	MM4A	Annulment/lapse due to non-payment of fees, searched and examined patent	Free format text: MAXIMUM VALIDITY LIMIT REACHED Effective date: 20080520

Date

Code

Title

Description

1992-09-30

FG3A

Patent granted, date of granting

Effective date: 19920311

2008-06-03

MM4A

Annulment/lapse due to non-payment of fees, searched and examined patent

Free format text: MAXIMUM VALIDITY LIMIT REACHED

Effective date: 20080520